Diabetic Neuropathy: Types, Symptoms, and Treatment

Roughly half of people with diabetes will develop some form of diabetic neuropathy during their lifetime, according to the National Institute of Diabetes and Digestive and Kidney Diseases. Diabetic neuropathy is nerve damage caused by chronically elevated blood sugar — and it can affect virtually every organ system in the body, from the feet to the heart to the digestive tract. Because nerve damage often develops gradually, many people do not notice symptoms until significant harm has already occurred. Early detection, tight glucose control, and targeted symptom management can slow progression, prevent complications, and improve quality of life. This guide is part of our broader medical conditions guide.

How Diabetes Damages Nerves

The exact mechanisms by which elevated blood sugar damages nerves are complex and multifactorial. The prevailing theory centers on metabolic pathways activated by hyperglycemia. Excess glucose is converted to sorbitol through the polyol pathway, which depletes NADPH and reduces the cell’s ability to handle oxidative stress. Simultaneously, advanced glycation end products (AGEs) accumulate in nerve tissue, triggering inflammation and damaging the small blood vessels (vasa nervorum) that supply the nerves with oxygen and nutrients.

Microvascular disease is a key contributor. The tiny blood vessels that nourish peripheral nerves become thickened and narrowed, reducing blood flow and causing ischemic damage to the nerve fibers. This process parallels how diabetes damages the blood vessels of the eyes (leading to diabetic retinopathy) and kidneys. The longer blood sugar remains poorly controlled, the greater the cumulative damage. Other factors — high triglycerides, high blood pressure, smoking, excess alcohol, and being overweight — independently add to the risk, which is why neuropathy is best understood as a whole-body metabolic problem, not just “high sugar.”

Both type 1 and type 2 diabetes can cause neuropathy, though the presentation may differ. In type 2 diabetes, neuropathy may already be present at diagnosis — reflecting years of undetected hyperglycemia or the damaging effects of prediabetes and insulin resistance. According to the American Diabetes Association, a meaningful share of people newly diagnosed with type 2 diabetes already show evidence of neuropathy, underscoring how early — and how silently — the process can begin.

Types of Diabetic Neuropathy

Peripheral Neuropathy

Peripheral neuropathy is by far the most common type, affecting the longest nerves first — which is why symptoms typically begin in the feet and toes before progressing to the hands and fingers (a pattern called “stocking-glove distribution”). Symptoms include numbness, tingling, burning pain, sharp or stabbing sensations, and heightened sensitivity to touch. Some patients describe a feeling of wearing invisible gloves or socks. As the condition progresses, loss of sensation can occur, which is particularly dangerous because injuries to the feet may go unnoticed, leading to ulcers and infections that can ultimately require amputation.

Autonomic Neuropathy

Autonomic neuropathy affects the nerves that control involuntary body functions. It can manifest in numerous ways: gastroparesis (delayed stomach emptying causing nausea, bloating, and unpredictable blood sugar), bladder dysfunction (difficulty emptying the bladder completely, urinary tract infections), sexual dysfunction (erectile dysfunction in men, vaginal dryness in women), cardiovascular autonomic neuropathy (resting tachycardia, orthostatic hypotension), and impaired ability to detect low blood sugar (hypoglycemia unawareness). Cardiovascular autonomic neuropathy is particularly concerning because it is associated with increased risk of silent heart attacks and sudden cardiac death.

Proximal Neuropathy (Diabetic Amyotrophy)

Proximal neuropathy, also called diabetic amyotrophy or diabetic lumbosacral radiculoplexus neuropathy, affects the nerves in the thighs, hips, buttocks, or legs — usually on one side. It causes sudden, severe pain followed by muscle weakness and wasting. This form is less common but can be profoundly disabling. It tends to occur in older adults with type 2 diabetes and often improves over months to years, though recovery may be incomplete.

Focal Neuropathy (Mononeuropathy)

Focal neuropathy involves damage to a single specific nerve, most commonly in the head, torso, or leg. It can cause sudden weakness or pain, such as Bell’s palsy (facial nerve), carpal tunnel syndrome (median nerve), or double vision (a cranial nerve). Focal neuropathy typically has a sudden onset and often resolves on its own over weeks to months, though it can be frightening and debilitating during the acute phase. New double vision, facial droop, or sudden weakness should always be evaluated promptly, because these symptoms can also be caused by more serious problems such as a stroke.

Recognizing the Symptoms Early

The challenge with diabetic neuropathy is that early symptoms are often subtle and easy to dismiss. Periodic tingling in the toes, mild numbness in the feet, or occasional digestive discomfort may not seem worth mentioning to a doctor. But these are precisely the symptoms that, when caught early, signal an opportunity for intervention.

Pay attention to changes in sensation in your feet and hands. Notice whether you can feel the difference between hot and cold water with your toes. Watch for balance problems, especially in the dark (when visual compensation for impaired proprioception is removed). Track any digestive symptoms — feeling full quickly, unexplained nausea, constipation alternating with diarrhea — as these may indicate autonomic involvement.

Men should be aware that erectile dysfunction can be an early sign of both autonomic neuropathy and cardiovascular disease. Women may notice changes in vaginal lubrication or sexual response. Dizziness on standing, unexplained rapid heart rate, and excessive or reduced sweating are all potential autonomic symptoms worth reporting. Per the Mayo Clinic and ADA Standards of Care, screening for peripheral neuropathy should begin at diagnosis for type 2 diabetes and five years after diagnosis for type 1, with at least annual foot checks thereafter.

Diagnosis and Testing

The diagnosis of diabetic neuropathy typically begins with a clinical exam. For peripheral neuropathy, your doctor will test sensation using a 10-gram monofilament (a thin nylon strand pressed against specific points on the foot) and a 128-Hz tuning fork to assess vibration perception. Loss of protective sensation on monofilament testing is one of the strongest predictors of future foot ulceration. Ankle reflexes are also tested, as their absence is an early sign of neuropathy.

Nerve conduction studies (NCS) and electromyography (EMG) provide objective measurement of nerve function. NCS measures how quickly electrical signals travel through peripheral nerves, while EMG assesses muscle electrical activity. These tests can confirm the diagnosis, gauge severity, and help distinguish diabetic neuropathy from other causes of nerve damage.

Importantly, not every case of numbness in a person with diabetes is diabetic neuropathy, so part of the workup is ruling out other treatable contributors — vitamin B12 deficiency (which can be worsened by long-term metformin use), thyroid disease, kidney disease, alcohol use, and certain medications. For autonomic neuropathy, specialized testing may include heart-rate-variability analysis, tilt-table testing for orthostatic hypotension, gastric-emptying studies for suspected gastroparesis, and bladder-function tests. Skin biopsy to measure intraepidermal nerve fiber density is increasingly used as a sensitive tool for detecting small-fiber neuropathy, which may not appear on standard nerve conduction studies.

Blood Sugar Control: The Foundation

Tight glycemic control is the most important modifiable factor in preventing and slowing diabetic neuropathy. The landmark Diabetes Control and Complications Trial (DCCT) demonstrated that intensive blood sugar management in type 1 diabetes substantially reduced the risk of developing neuropathy. The EDIC follow-up study showed these benefits persisted for years, even after the period of intensive control ended — a concept known as “metabolic memory.”

In type 2 diabetes, the relationship between glucose control and neuropathy is real but more modest, and controlling other risk factors (blood pressure, lipids, weight, and smoking) matters alongside glucose. Many adults aim for an A1C target of below 7%, but individual targets should be set with your healthcare provider, considering age, other health conditions, and the risk of hypoglycemia — a higher target is often safer for older adults or those prone to lows. Some newer diabetes medications also offer cardiovascular and kidney benefits, which your clinician can factor into your overall plan.

Beyond average blood sugar (A1C), glucose variability — the size of blood-sugar swings throughout the day — may also contribute to nerve damage. Avoiding dramatic highs and lows through consistent meal timing, medication adherence, and physical activity provides additional benefit. Continuous glucose monitoring can help identify patterns of variability that need to be addressed.

Pain Management

Painful diabetic neuropathy is one of the most challenging aspects of the condition, affecting a substantial minority of people with diabetes. The pain — often described as burning, stabbing, or electric-shock-like — can be debilitating and severely impair sleep, mood, and daily function. Standard pain relievers like acetaminophen and ibuprofen are generally ineffective for neuropathic pain.

First-line medication classes for painful diabetic neuropathy include gabapentinoids (such as pregabalin and gabapentin), SNRIs (such as duloxetine), tricyclic antidepressants (such as amitriptyline and nortriptyline), and certain sodium-channel blockers. Pregabalin and duloxetine are FDA-approved for this indication; the American Academy of Neurology, in its updated guidance on painful diabetic neuropathy, treats these classes as broadly comparable options and recommends choosing based on a patient’s other conditions, side-effect profile, cost, and preferences. This article deliberately gives no doses: these medications are titrated and monitored by a prescriber, and several carry meaningful side effects (dizziness, drowsiness, nausea) or cautions.

Topical options such as capsaicin and lidocaine patches can provide localized relief for some people. Opioids are not recommended for chronic neuropathic pain because of limited long-term benefit and serious risks including dependence, tolerance, and paradoxical worsening of pain (hyperalgesia). Non-drug approaches — transcutaneous electrical nerve stimulation (TENS), structured exercise, physical therapy, and cognitive behavioral therapy for pain — can add meaningful benefit and are worth discussing with your clinician.

Foot Care and Amputation Prevention

Diabetic foot complications are among the most devastating consequences of peripheral neuropathy. A significant share of people with diabetes — on the order of one in six to one in four over a lifetime — will develop a foot ulcer, and diabetic foot ulcers precede the large majority of diabetes-related amputations, according to the American Podiatric Medical Association and CDC data. The sequence is predictable: neuropathy causes loss of sensation, minor injuries go unnoticed, and poor blood flow (peripheral arterial disease) impairs healing, allowing infection to take hold.

Daily foot inspection is non-negotiable for anyone with diabetic neuropathy. Check your feet every day for cuts, blisters, redness, swelling, or changes in skin temperature. Use a mirror or ask a family member to examine areas you cannot see. Wash your feet daily in lukewarm (not hot) water, dry them thoroughly — especially between the toes — and apply moisturizer to prevent cracking (but not between the toes).

Wear well-fitting shoes at all times, including indoors. Never walk barefoot. Have your feet measured and fitted by a professional, and consider therapeutic shoes or custom orthotics if you have foot deformities or a history of ulcers. Trim toenails straight across and avoid “bathroom surgery” on calluses or ingrown nails — see a podiatrist instead. Regular podiatric care is a covered benefit under Medicare for qualifying patients with diabetes.

Managing Autonomic Complications

Autonomic neuropathy requires targeted management of each affected organ system, always under clinician guidance. For gastroparesis, dietary modifications (small, frequent, low-fat, low-fiber meals) and specific medications can improve gastric emptying. For orthostatic hypotension, increasing fluid and salt intake (when appropriate), wearing compression stockings, and rising slowly from sitting or lying positions are first steps; medications may be added if needed.

Bladder dysfunction is managed with timed voiding, intermittent catheterization if necessary, and medications selected to the specific problem (urinary retention versus overactive bladder). Erectile dysfunction may respond to phosphodiesterase-5 inhibitors, vacuum devices, or other treatments. Cardiovascular autonomic neuropathy requires close monitoring and aggressive management of cardiovascular risk factors, including blood pressure, cholesterol, and smoking cessation.

Hypoglycemia unawareness — the loss of warning symptoms like shakiness, sweating, and hunger before blood sugar drops dangerously low — is one of the most dangerous autonomic complications, because it sharply raises the risk of severe lows. Management involves relaxing blood-sugar targets, using continuous glucose monitoring with alarms, and ensuring family or housemates know how to use glucagon. Understanding the financial aspects of these devices and treatments is important for long-term planning.

Frequently Asked Questions

Can diabetic neuropathy be reversed?

In early stages — particularly during the prediabetes or early-diabetes phase — some nerve recovery is possible with strict blood sugar control and lifestyle change. Once nerve fibers are significantly damaged, however, regeneration is limited. The primary goals become halting progression, managing symptoms, and preventing complications like foot ulcers. Early detection and intervention offer the best chance to preserve nerve function.

Does diabetic neuropathy always cause pain?

No. Many people experience numbness rather than pain, and some have no symptoms at all despite detectable nerve damage on testing. Painless neuropathy can be more dangerous in some ways, because the loss of protective sensation lets injuries go unnoticed, leading to foot ulcers and infections.

What is the best medication for diabetic neuropathy pain?

There is no single “best” medication — response varies from person to person. Pregabalin and duloxetine are FDA-approved and commonly used first, with gabapentin and tricyclic antidepressants as alternatives; guidelines treat these classes as broadly comparable. Many people need to try more than one before finding adequate relief, sometimes in combination. Work with your prescriber, who will select and adjust treatment based on your other conditions and how you respond.

How can I tell the difference between diabetic neuropathy and other causes of numbness?

The symmetric “stocking-glove” pattern starting in both feet is highly suggestive of diabetic neuropathy in someone with diabetes. However, other conditions — vitamin B12 deficiency, thyroid disease, kidney disease, alcohol use, and medication side effects — can cause similar symptoms. Your doctor may order blood tests and nerve conduction studies to confirm the diagnosis and rule out other causes.

Should I see a neurologist for diabetic neuropathy?

A neurologist can be valuable if symptoms are atypical, if pain is hard to control, or if a non-diabetic cause is suspected. For straightforward peripheral neuropathy, many primary care physicians and endocrinologists manage the condition effectively. A team approach involving a podiatrist, pain specialist, and physical therapist may be ideal for comprehensive management.

Protecting Your Nerves for the Long Term

Diabetic neuropathy is not an inevitable consequence of diabetes. Keep your A1C as close to your individualized target as safely possible, and manage blood pressure, cholesterol, and weight alongside it. Check your feet every single day — make it as automatic as brushing your teeth. Report new symptoms promptly, even if they seem minor. Attend your annual foot exams and neuropathy screenings. If you are prescribed medication for neuropathic pain, give it adequate time to work (many take weeks to reach full effect) and communicate honestly with your doctor about whether it is helping.

Lifestyle factors matter enormously. Regular exercise improves blood flow to peripheral nerves, enhances glucose control, and may support nerve health. Avoid excess alcohol, which independently damages nerves, and do not smoke. Ensure adequate B12, which can be depleted by long-term metformin use. Diabetic neuropathy is a manageable condition — but only if you and your healthcare team manage it actively, and only if a foot problem is treated as the urgent matter it can quickly become.

Sources

• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) — diabetic neuropathies overview, types, and prevention
• American Diabetes Association — Standards of Care, neuropathy screening, and glycemic targets
• Mayo Clinic — symptoms, types, and diagnosis of diabetic neuropathy
• American Academy of Neurology — guideline on oral and topical treatments for painful diabetic neuropathy
• American Podiatric Medical Association and CDC — diabetic foot ulcers, amputation risk, and foot-care guidance